Hong Kong Pharma Digital Technology Holdings revenue was $20.31M for the trailing 12 months ending Mar 31, 2025, with N/A growth year over year. Quarterly revenue for the quarter (Q1 2025) ending on Mar 31, 2025 was N/A, down N/A from last quarter. For the last reported fiscal year 2025 ending Mar 31, 2025, HKPD annual revenue was $20.3M, with 21.7% growth year-over-year.
HKPD past revenue growth
How has HKPD's revenue growth performed historically?
Hong Kong Pharma Digital Technology Holdings Revenue FAQ
What was HKPD's revenue last quarter?
Hong Kong Pharma Digital Technology Holdings (NASDAQ: HKPD) reported Q1 2025 revenue of N/A up N/A year over year. In the same quarter last year, Hong Kong Pharma Digital Technology Holdings's revenue was N/A.
What was Hong Kong Pharma Digital Technology Holdings's revenue in 2025?
Hong Kong Pharma Digital Technology Holdings's annual revenue for the twelve months ending Mar 31, 2025 was $20.31 million, a 21.72% increase year over year.
How much does Hong Kong Pharma Digital Technology Holdings make in a day?
Based on Hong Kong Pharma Digital Technology Holdings annual revenue for the past two years, HKPD makes an average of $50,687.92 per day.
What was Hong Kong Pharma Digital Technology Holdings's annual revenue growth in the past year?
As of Q3 2025, Hong Kong Pharma Digital Technology Holdings's revenue has grown 21.72% year over year. This is 11.87 percentage points higher than the US Leisure industry revenue growth rate of 9.86%. Hong Kong Pharma Digital Technology Holdings's revenue in the past year totaled $20.31 million.
How much does Hong Kong Pharma Digital Technology Holdings make in a year?
Hong Kong Pharma Digital Technology Holdings's revenue by year for the past two years is:
Hong Kong Pharma Digital Technology Holdings's revenue for the twelve months ending Mar 31, 2025 was $20.31 million, a 21.72% increase year over year.
Hong Kong Pharma Digital Technology Holdings's annual revenue for Mar 31, 2024 was $16.69 million, a 32.91% increase from 2023.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.